# Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/impact-of-glucagon-like-peptide-1-receptor-agonist-and-sodium-glucose/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Takeyuki Hiramatsu,Hiroki Ito,Shota Okumura,Yuko Asano,Daiki Iguchi,Shinji Furuta |
| Citations | 15 |
| DOI | 10.1177/1479164120971220 |
| Fields | Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://journals.sagepub.com/doi/pdf/10.1177/1479164120971220 |
| OpenAlex ID | https://openalex.org/W3116719029 |
| PMID | 33371732 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Daiki Iguchi](https://scholariq.org/researchers/daiki-iguchi/)
- [Shinji Furuta](https://scholariq.org/researchers/shinji-furuta/)

## Paper journal

- [Diabetes and Vascular Disease Research](https://scholariq.org/journals/diabetes-and-vascular-disease-research/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.